Loading…

Multiple sclerosis: immunomodulators, education, and self-injection

One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more than 3 months completed a self-administered questionnaire. More than 60p.cent of the patients performed self-injection. For both modes of inject...

Full description

Saved in:
Bibliographic Details
Published in:Revue neurologique 2007-12, Vol.163 (12), p.1209
Main Authors: Moinot, N, Anne, O, Devoize, J-L, Artaut-Uriot, M S, Aubert-Cetou, I, Boissonnot, L, Debras, C, Lebras, F, Loll, P-Y, Godeneche, G, Mesnage, V, Neau, J-P
Format: Article
Language:fre
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One hundred and sixty four patients of the Poitou-Charentes area suffering from multiple sclerosis (MS) and treated with an immunomodulating agent for more than 3 months completed a self-administered questionnaire. More than 60p.cent of the patients performed self-injection. For both modes of injection studied (subcutaneous or intramuscular), self-injection was significantly more frequent among patients who were received training and followed via telephone assistance conducted by a nurse with specialized training in MS. Our study demonstrated that waste disposal (needles), especially among patients performing self-injections, remains an important problem. Efforts must be taken concerning this important healthcare issue.
ISSN:0035-3787
DOI:10.1016/S0035-3787(07)78405-9